PIL Price sensitive 30 Apr 2026, 1:44 PM

Quarterly Activities/Appendix 4C Cash Flow Report

Peppermint Innovation Ltd

Peppermint Innovation reports Q1 2026 results

Key points

  • Successful rollout of QRPh Person-to-Merchant (P2M) capability
  • A$2.1 million strategic investment from Philippine payments sector partners
  • Resolution of Obsidian dispute, positioning for ASX reinstatement

Full summary

Peppermint Innovation Ltd (ASX:PIL) has reported its Quarterly Activities Report and Operational Update for the period ended 31 March 2026. Key highlights include the successful rollout of QRPh Person-to-Merchant (P2M) capability, a A$2.1 million strategic investment from Philippine payments sector partners, and the resolution of the Obsidian dispute, positioning the company for ASX reinstatement. The company continued to see growth in Pinoy Coop Mobile (PCM) registered users, wallet prefunding, and transaction activity across ATM-to-bizmoto cash-in and InstaPay/PESONet transfers. Peppermint also focused on strengthening platform scalability, security, and P2M infrastructure to support higher transaction volumes and merchant onboarding. The strategic investment from Philippine payments sector participants provides growth capital and represents strong external validation of Peppermint's regulated infrastructure, with these groups seeking to leverage the company's EMI licence and access to national payment rails. With the Obsidian matter resolved, Peppermint is now focused on scaling transaction volumes, increasing active users, and executing on its next phase of growth as a fully regulated digital payments platform.

Guidance

Peppermint expects continued growth in transaction volumes and active users across its digital payments platform through 2026.

Outlook

Peppermint is targeting continued expansion of its merchant network and payment processing capability through 2026, supported by its regulatory position and growing ecosystem of partners.

Summary generated by a large language model. Please interpret with care.

Sign in for more about this company, including guidance changes and other insights.
Sign in